MEDICAL devices developer Visiomed Group has secured the crucial regulatory clearance that paves the way for the commercialisation of its Funhaler asthma spacer into the lucrative US market.
18/01/2005 - 21:00
Way to healthy market cleared
18/01/2005 - 21:00
